APA (7th ed.) Citation

Sato-Nagaoka, Y., Suzuki, S., Suzuki, S., & Takahashi, S. (2024). Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells. PLoS ONE, 19(12), 1. https://doi.org/10.1371/journal.pone.0312406

Chicago Style (17th ed.) Citation

Sato-Nagaoka, Yuri, Susumu Suzuki, Souma Suzuki, and Shinichiro Takahashi. "Combination of Triciribine and P38 MAPK Inhibitor PD169316 Enhances the Differentiation Effect on Myeloid Leukemia Cells." PLoS ONE 19, no. 12 (2024): 1. https://doi.org/10.1371/journal.pone.0312406.

MLA (9th ed.) Citation

Sato-Nagaoka, Yuri, et al. "Combination of Triciribine and P38 MAPK Inhibitor PD169316 Enhances the Differentiation Effect on Myeloid Leukemia Cells." PLoS ONE, vol. 19, no. 12, 2024, p. 1, https://doi.org/10.1371/journal.pone.0312406.